Actinium Pharmaceuticals (ATNM) Q3 2023 Earnings

2NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.51
-0.34
-0.17
0

Details

Expected EPS
-0.51
Actual EPS
-0.49
Surprise EPS
0.02
Surprise Percent
+3.92%

Description

Actinium Pharmaceuticals (ATNM) has reported earnings of -0.49 per share for Q3 2023.

0 Comments

Share your thoughts